Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0001554,
umls-concept:C0004112,
umls-concept:C0017262,
umls-concept:C0022116,
umls-concept:C0023810,
umls-concept:C0024432,
umls-concept:C0035696,
umls-concept:C0128897,
umls-concept:C0185117,
umls-concept:C0205100,
umls-concept:C0443199,
umls-concept:C1280500,
umls-concept:C1882598,
umls-concept:C2911684
|
pubmed:issue |
1-2
|
pubmed:dateCreated |
1997-4-24
|
pubmed:abstractText |
Increasing evidence indicates a key role of chemoattractant cytokines in the accumulation of leukocytes in the central nervous system (CNS) during the course of inflammatory processes. Monocyte chemoattractant protein (MCP-1/JE), a member of the beta-chemokine (C-C chemokine) family, functions as a potent chemoattractant and activator for monocytes. We have investigated the induction of MCP-1 mRNA using in situ hybridization histochemistry (ISH) and characterized its cellular source by combination of ISH and immunocytochemistry in ischemic rat brains as well as in brains of endotoxin-treated rats. Our results show that 6 h-2 d after middle cerebral artery occlusion (MCAO), MCP-1 mRNA is present in astrocytes surrounding the ischemic tissue (penumbra). At later time points (after 4 d), MCP-1 mRNA is found in macrophages and reactive microglia in the infarcted tissue. Peripheral administration of the bacterial lipopolysaccharide (LPS) induced MCP-1 mRNA throughout the brain in a time-dependent manner (1 h-1 d, peak of expression 6-8 h) and was found in astrocytes. In summary, we have found expression of MCP-1 in (a) astrocytes and to a lesser extent in macrophages/reactive microglia after MCA-occlusion and in (b) astrocytes after peripheral administration of LPS. These findings support that MCP-1 is involved in the CNS response to acute trauma or infection and thus may play a key role in inflammatory processes of the brain.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0165-5728
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
74
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
35-44
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9119977-Animals,
pubmed-meshheading:9119977-Astrocytes,
pubmed-meshheading:9119977-Brain,
pubmed-meshheading:9119977-Brain Ischemia,
pubmed-meshheading:9119977-Chemokine CCL2,
pubmed-meshheading:9119977-Immunohistochemistry,
pubmed-meshheading:9119977-In Situ Hybridization,
pubmed-meshheading:9119977-Lipopolysaccharides,
pubmed-meshheading:9119977-Macrophages,
pubmed-meshheading:9119977-Male,
pubmed-meshheading:9119977-RNA, Messenger,
pubmed-meshheading:9119977-Rats,
pubmed-meshheading:9119977-Rats, Sprague-Dawley,
pubmed-meshheading:9119977-Time Factors,
pubmed-meshheading:9119977-Tissue Distribution
|
pubmed:year |
1997
|
pubmed:articleTitle |
Differential and time-dependent expression of monocyte chemoattractant protein-1 mRNA by astrocytes and macrophages in rat brain: effects of ischemia and peripheral lipopolysaccharide administration.
|
pubmed:affiliation |
Sandoz Pharma Ltd., Preclinical Research, Basel, Switzerland.
|
pubmed:publicationType |
Journal Article
|